PDB40 COST-UTILITY OF BIPHASIC INSULIN ASPART COMPARED WITH PREMIXED HUMAN INSULIN IN TREATMENT OF TYPE-2 DIABETES MELLITUS IN POLAND

Article OPEN
Szmurlo, D; Gurda-Duda, A; Rys, P; Rutkowski, J; Skrzekowska-Baran, I; Plisko, R; Wladysiuk, M;
(2009)
Share - Bookmark